Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2010-03-23 |
| Study Made Public: | 2011-08-08 |
Title
Priming for neutralising antibody responses in rabbits by electroporation of HIV env and gag DNA, boosting with virus-like particles.
Description
CAVD 315 is a preclinical rabbit study investigating several prime-boost regimens in which plasmid DNA (HIV gag) or env gp160 and gp41 proteins were boosted with mimotope from the env gp41 region with cholera toxin B as an immune stimulator.
Sign in to see full information about this study and to download study data.
Products
CFA IFA CN54env-gp140 CN54env-gp145 CTM-2F5 R2env-gp140 VLP-CTB VLP-CTB mimotope VLP-GAG VLP-R2 pCDNA-R2 pCDNA-gagIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.